XOMA Corporation (XOMAO)
- Previous Close
25.09 - Open
25.00 - Bid --
- Ask --
- Day's Range
25.00 - 25.00 - 52 Week Range
20.43 - 25.85 - Volume
1,001 - Avg. Volume
2,519 - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
24.98 - EPS (TTM)
1.00 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield 2.09 (8.34%)
- Ex-Dividend Date Apr 2, 2024
- 1y Target Est
--
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
www.xoma.comRecent News: XOMAO
Performance Overview: XOMAO
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XOMAO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XOMAO
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-8.09%
Return on Equity (ttm)
-40.24%
Revenue (ttm)
5.81M
Net Income Avi to Common (ttm)
-45.09M
Diluted EPS (ttm)
1.00
Balance Sheet and Cash Flow
Total Cash (mrq)
136.64M
Total Debt/Equity (mrq)
147.01%
Levered Free Cash Flow (ttm)
-10.48M
Research Analysis: XOMAO
Company Insights: XOMAO
XOMAO does not have Company Insights